Cardinal Health Reports Q4 and Fiscal 2017 Results, Provides 2018 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Cardinal Health (CAH) PT Lowered to $77 at Cowen Following 4Q Report
August 2, 2017 4:05 PM EDTCowen lowered its price target on Cardinal Health (NYSE: CAH) to $77.00 (from $82.00) while maintaining a Market Perform rating. CAH reported adjusted EPS of $1.31 that was above the consensus estimates of $1.24, but would have missed without a tax benefit.
Management announced F2018 adjusted EPS... More
Cardinal Health (CAH) Tops Q4 EPS by 7c; Guides Short of Views
August 2, 2017 7:02 AM EDTCardinal Health (NYSE: CAH) reported Q4 EPS of $1.31, $0.07 better than the analyst estimate of $1.24. Revenue for the quarter came in at $33 billion versus the consensus estimate of $32.73 billion.
GUIDANCE:
Cardinal Health sees FY2018 EPS of $4.85-$5.10, versus the consensus of... More
